Larvol Delta - Prospective-Multicenter-Randomized-Controlled-Study-of-TargetImmunotherapy-Combined-with-Local-Treatment-for-Hepatocellular-Carcinoma-with-VP34-Portal-Vein-Tumor-Thrombus

AiTan (rivoceranib) - Elevar Therapeutics

AiRuiKa (camrelizumab) - Elevar Therapeutics

https://www.chictr.org.cn/showproj.html?proj=323236

Jul 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next